Evidence map›Paper›PMID 30596012›Full record

ArticleIntegrative medicine research2019

Moxibustion for prehypertension and stage I hypertension: a pilot randomized controlled trial.

Kyung-Min Shin, Ji-Eun Park, Tae-Han Yook, Jong-Uk Kim, Ojin Kwon, Sun-Mi Choi

Open access · goldAbstract read
In one paragraph

Article in Integrative medicine research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kyung-Min ShinClinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
Ji-Eun ParkFuture Medicine Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
Tae-Han YookDepartment of Acupuncture & Moxibustion Medicine, Korean Medicine Hospital of Woosuk University, Jeonju, South Korea.
Jong-Uk KimDepartment of Acupuncture & Moxibustion Medicine, Korean Medicine Hospital of Woosuk University, Jeonju, South Korea.
Ojin KwonClinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, South Korea.
Sun-Mi ChoiKorea Institute of Oriental Medicine, Daejeon, South Korea.
Korea Institute of Oriental Medicine · KRWoosuk University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrehypertension and hypertension are associated with cardiovascular disease, ischemic heart disease, and stroke morbidity. The purpose of this study is to evaluate the effectiveness and safety of moxibustion in patients with prehypertension or hypertension.

methodsForty-five subjects with prehypertension or stage I hypertension were randomized into three groups: moxibustion treatment group A (2 sessions/week for 4 weeks), moxibustion treatment group B (3 sessions/week for 4 weeks), and control group (nontreated group). The primary outcome measure was the change in blood pressure after 4 weeks of treatment. Safety was assessed at every visit.

resultsThere were no significant differences in systolic blood pressure (SBP) or diastolic blood pressure (DBP) among three groups after 4 weeks of treatment (

conclusionIn conclusion, the results of this study show that moxibustion (3 sessions/week for 4 weeks) might lower blood pressure in patients with prehypertension or stage I hypertension and treatment frequency might affect effectiveness of moxibustion in BP regulation. Further randomized controlled trials with a large sample size on prehypertension and hypertension should be conducted.

trial registrationThis study was registered with the 'Clinical Research Information Service (CRIS)', Republic of Korea (KCT0000469), and the protocol for this study was presented orally at the 15th International Council of Medical Acupuncture and Related Techniques (ICMART) in Athens, 25-27 May 2012.

Indexed as

AE, adverse eventBMI, body mass indexBP, blood pressureCI, confidence intervalDBP, diastolic blood pressureEQ-5D, EuroQol-5 DimensionsFSS, Fatigue Severity ScaleHRV, heart rate variabilityHypertensionMD, mean differenceMoxibustionNDI, neck disability indexPrehypertensionPSQI, Pittsburgh Sleep Quality IndexRCT, randomized controlled trialSAE, serious adverse eventSBP, systolic blood pressureSRI-MF, Modified Form of the Stress Response Inventory

Identifiers

PMID30596012
PMCPMC6309023
OpenAlexW2901947596

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.